- Home
- RA vs PSNL Comparison
RA vs PSNL Comparison
Compare RA & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RA
- PSNL
- Stock Information
- Founded
- RA 2016
- PSNL 2011
- Country
- RA United States
- PSNL United States
- Employees
- RA 1260
- PSNL 229
- Industry
- RA Investment Managers
- PSNL Medical Specialities
- Sector
- RA Finance
- PSNL Health Care
- Exchange
- RA Nasdaq
- PSNL Nasdaq
- Market Cap
- RA 711.7M
- PSNL 562.6M
- IPO Year
- RA N/A
- PSNL 2019
- Fundamental
- Price
- RA $13.19
- PSNL $6.19
- Analyst Decision
- RA
- PSNL Strong Buy
- Analyst Count
- RA 0
- PSNL 5
- Target Price
- RA N/A
- PSNL $8.00
- AVG Volume (30 Days)
- RA 280.8K
- PSNL 1.8M
- Earning Date
- RA 01-01-0001
- PSNL 08-06-2025
- Dividend Yield
- RA 14.73%
- PSNL N/A
- EPS Growth
- RA N/A
- PSNL N/A
- EPS
- RA N/A
- PSNL N/A
- Revenue
- RA N/A
- PSNL $85,694,000.00
- Revenue This Year
- RA N/A
- PSNL $0.45
- Revenue Next Year
- RA N/A
- PSNL $25.75
- P/E Ratio
- RA N/A
- PSNL N/A
- Revenue Growth
- RA N/A
- PSNL 15.57
- 52 Week Low
- RA $11.89
- PSNL $2.22
- 52 Week High
- RA $17.32
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- RA 52.29
- PSNL 48.39
- Support Level
- RA $13.25
- PSNL $6.19
- Resistance Level
- RA $13.40
- PSNL $6.60
- Average True Range (ATR)
- RA 0.08
- PSNL 0.51
- MACD
- RA -0.02
- PSNL -0.13
- Stochastic Oscillator
- RA 1.08
- PSNL 4.48
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.